| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Samaranayake LP | |
| Teanpaisan R | |||
| Sweet SP | |||
| Coogan MM | |||
| Blignaut E | |||
| Fidel PL | |||
| Wanzala P | |||
| Naglik JR | |||
| P2860 | cites work | Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans | Q24550731 |
| A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport | Q28266457 | ||
| In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors | Q28368771 | ||
| The periodontal health of homosexual men with HIV infection: a controlled study. | Q30492382 | ||
| Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate | Q33630438 | ||
| Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis | Q33701491 | ||
| Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. | Q33721804 | ||
| Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy | Q33800801 | ||
| In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis | Q33867435 | ||
| Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases | Q34398225 | ||
| Oral candidal infections and antimycotics | Q34632651 | ||
| Resistance of Candida species to fluconazole | Q35110522 | ||
| High prevalence of antifungal resistance in Candida spp. from patients with AIDS. | Q47650748 | ||
| Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. | Q54072268 | ||
| Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity | Q61441063 | ||
| Longitudinal study of parotid saliva in HIV-1 infection | Q67559317 | ||
| Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir | Q71074018 | ||
| Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells | Q71514544 | ||
| Nystatin pastilles and suspension in the treatment of oral candidosis | Q71713811 | ||
| Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology | Q71972430 | ||
| Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS | Q72025281 | ||
| Median rhomboid glossitis. An oral manifestation in patients infected with HIV | Q72169299 | ||
| Fluconazole resistant oral candidiasis in HIV-infected patients | Q74145465 | ||
| Effect of HAART on natural history of AIDS-related opportunistic disorders | Q74147323 | ||
| Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters | Q35120105 | ||
| Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis | Q35136158 | ||
| Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis | Q35137341 | ||
| Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species | Q35138571 | ||
| Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis | Q35410834 | ||
| Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. | Q35467162 | ||
| Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. | Q35774918 | ||
| Fluconazole resistance in Candida glabrata | Q35819599 | ||
| Oral mycoses in HIV infection. | Q35922308 | ||
| Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients | Q36525223 | ||
| Amphotericin B: an introduction | Q36929998 | ||
| Candida dubliniensis fungemia: the first four cases in North America | Q37065084 | ||
| Emerging disease issues and fungal pathogens associated with HIV infection | Q37091704 | ||
| Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic | Q37138602 | ||
| Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy | Q37233028 | ||
| Genetic mechanisms of drug resistance. A review | Q37679117 | ||
| Oral manifestations of HIV infection in 600 South African patients. | Q38879171 | ||
| Adhesion and association mechanisms of Candida albicans | Q39644913 | ||
| Characterization of an azole-resistant Candida glabrata isolate | Q40088759 | ||
| Antifungal prophylaxis in immunocompromised hosts | Q40874801 | ||
| Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches | Q40878512 | ||
| Resistance of yeasts to azole-derivative antifungals | Q40918799 | ||
| Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities | Q40938533 | ||
| Loss of periodontal attachment in HIV-seropositive military personnel. | Q40984673 | ||
| Sequence comparison of yeast ATP-binding cassette proteins | Q41125030 | ||
| Refractory mucosal candidiasis in patients with human immunodeficiency virus infection | Q41730963 | ||
| Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. | Q42655153 | ||
| Involvement of Candida albicans cell wall proteins in the adherence of blastospores to human buccal epithelial cells | Q43443912 | ||
| In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents | Q43600536 | ||
| Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. | Q43621423 | ||
| Is there an association between periodontal condition and HIV infection? | Q43740610 | ||
| Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients | Q43888446 | ||
| Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome | Q44170824 | ||
| Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men | Q44218018 | ||
| Factors associated with increased frequency of HIV-related oral candidiasis | Q44718316 | ||
| Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis | Q45259556 | ||
| In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus | Q45740966 | ||
| Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection | Q45745986 | ||
| Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents | Q45758681 | ||
| Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology | Q45762381 | ||
| Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients | Q45767645 | ||
| Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus | Q45773827 | ||
| Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus | Q45781341 | ||
| Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles | Q45786121 | ||
| Periodontal status of individuals in early stages of human immunodeficiency virus infection | Q45857828 | ||
| Microbiological study of HIV-related periodontitis. | Q46032601 | ||
| The microbiology of HIV-associated periodontal lesions | Q46372746 | ||
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 151-160 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Oral Diseases | Q15724675 |
| P1476 | title | Fungal infections associated with HIV infection | |
| P478 | volume | 8 Suppl 2 |
| Q46885843 | (B1) Candida and mycotic infections |
| Q50083006 | A novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: "Neutrophil Anergy". |
| Q41998704 | Biofilm-forming ability and adherence to poly-(methyl-methacrylate) acrylic resin materials of oral Candida albicans strains isolated from HIV positive subjects |
| Q39789893 | Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection |
| Q33300915 | Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation |
| Q38163927 | Candida glabrata: a review of its features and resistance |
| Q38019018 | Candida species: new insights into biofilm formation. |
| Q44390209 | Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms |
| Q46775225 | Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline |
| Q28539436 | Coriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression |
| Q41526027 | Detection and quantification of fluconazole within Candida glabrata biofilms |
| Q43750492 | Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression |
| Q28067438 | Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis |
| Q46332887 | Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability? |
| Q51684416 | Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. |
| Q34582330 | Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia |
| Q46533651 | Fungal growth inhibitory properties of new phytosphingolipid analogues. |
| Q33837176 | Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans |
| Q43094518 | In vitro biofilm activity of non-Candida albicans Candida species. |
| Q36294066 | Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management |
| Q31137858 | Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma |
| Q37713936 | Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid. |
| Q37579679 | Proteomic Analysis of Intracellular and Membrane Proteins From Voriconazole-Resistant Candida glabrata |
| Q60937820 | Proteomic analysis of serum proteins from HIV/AIDS patients with infection by TMT labeling-based quantitative proteomics |
| Q35926440 | Rapid detection of Candida species in bronchoalveolar lavage fluid from patients with pulmonary symptoms |
| Q33359301 | Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis |
| Q36530366 | Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis |
| Q60222627 | The effect of antiretroviral therapy on the prevalence of HIV-associated oral candidiasis in a Spanish cohort |
| Q40136133 | The synthetic killer peptide KP impairs Candida albicans biofilm in vitro |
| Q45979192 | [Prevalence of oral lesions in persons with HIV and associated factors in a southern Brazilian city]. |
Search more.